Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jamie Gao"'
Autor:
Daniel K. Benjamin, Adam Schwarz, Jamie Gao, P. Brian Smith, Tracy Spears, Adam M. Bressler, John K. McGuire, Marian G. Michaels, Robert W. Frenck, Jessica E. Ericson, Jaime G. Deville, John S. Bradley, Swati Agarwal
Publikováno v:
Pediatric Infectious Disease Journal. 39:658-664
BACKGROUND Clinical trials for antibiotics designed to treat hospital-acquired and ventilator-associated bacterial pneumonias (HABP/VABP) are hampered by making these diagnoses in a way that is acceptable to the United States Food and Drug Administra
Autor:
Gratias Mundakel, Gregory M. Sokol, Sherry E. Courtney, Daniel K. Benjamin, Joseph M. Bliss, Jörn-Hendrik Weitkamp, Mark L. Hudak, Gaurav Sharma, Jinson Erinjeri, Matthew A. Saxonhouse, Jamie Gao, P. Brian Smith, Christiane E.L. Dammann, Julie Debski, Gloria P Heresi, Catherine M. Bendel, Barry T. Bloom, C. Michael Cotten, Julie Autmizguine, Angelique E Boutzoukas, Adrian Lavery, Erin K. Zinkhan, Michael J. Smith, Susan R. Mendley, Christoph P. Hornik, Michael Cohen-Wolkowiez
Publikováno v:
Pediatr Infect Dis J
BACKGROUND: In premature infants, complicated intra-abdominal infections (cIAIs) are a leading cause of morbidity and mortality. Although universally prescribed, the safety and effectiveness of commonly used antibiotic regimens has not been establish
Autor:
Julie Debski, Erin K Zinkhan, Fernando Moya, Sarah Jane Commander, Paula Delmore, Gaurav Sharma, Gloria Heresi, Christoph P. Hornik, Jinson Erinjeri, Tedryl G Bumpass, Gregory M Sokol, P. Brian Smith, Adrian Lavery, Sherry E. Courtney, Jamie Gao, Michael Cohen-Wolkowiez, Elisabeth T. Tracy, Daniel K. Benjamin
Publikováno v:
Pediatr Infect Dis J
BACKGROUND: Metronidazole is frequently used off-label in infants with complicated intra-abdominal infections (cIAI) to provide coverage against anaerobic organisms, but its safety and efficacy in this indication are unknown. METHODS: In the Antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::892b5955f936ebc0d54073ababd222e4
https://europepmc.org/articles/PMC10060863/
https://europepmc.org/articles/PMC10060863/
Autor:
Jessica E. Ericson, Paresh Pandit, Natalie Neu, Michael J. Smith, Agnes Perenyi, Margarita Bidegain, Anand Kantak, Catherine M. Bendel, Robert L. Schelonka, Mark L. Hudak, Brenda B. Poindexter, Stephen D. Kicklighter, Shahnaz Duara, Dan L. Stewart, Antonio Arrieta, Karen E. Shattuck, Jamie Gao, David Burchfield, Roger Kim, Scott Macgilvray, Michael Cohen-Wolkowiez, Mohan Pammi, Edmund V. Capparelli, Rune Toms, Jatinder Bhatia, Katherine Y. Berezny, Jonathan Nedrelow, Traci Clemons, Barry R. Bloom, Phillip Gordon, David A. Siegel, Ravinder Anand, Gregory L. Kearns, Kelly C. Wade, Gratias Mundakel, Matthew M. Laughon, Pablo J. Sánchez, Echezona E. Ezeanolue, David A. Kaufman, Perdita Taylor-Zapata, Seetha Shankaran, Zhaoxia Ren, Ramasubbareddy Dhanireddy, John N. van den Anker, Kathleen A. Kennedy, Ashley Ross, Robert D. White, Ian M. Paul, Daniel K. Benjamin, Anne Zajicek, Alice Pagan, Kristi Prather, Daniela Testoni, Ekaterini Tsilou, Neil Finer, P. Brian Smith, Gina A. Simone
Publikováno v:
Clinical Infectious Diseases. 63:604-610
Background Invasive candidiasis (IC) is an important cause of sepsis in premature infants and is associated with a high risk of death and neurodevelopmental impairment. Prevention of IC has become a major focus in very low birth weight infants, with
Autor:
Julie Autmizguine, Pablo J. Sánchez, Kristi Prather, Roger Kim, Mark L. Hudak, Kelly C. Wade, Catherine M. Bendel, Dan L. Stewart, Robert E. White, Echezona E. Ezeanolue, Paresh Pandit, Gratias Mundakel, Scott Macgilvray, Jamie Gao, Seetha Shankaran, Shahnaz Duara, Neil N. Finer, Natalie Neu, David J. Burchfield, Barry R. Bloom, Brenda B. Poindexter, David A. Kaufman, Agnes Perenyi, Rune Toms, Margarita Bidegain, Girija Natarajan, Anand Kantak, Daniel K. Benjamin, Jonathan Nedrelow, Karen E. Shattuck, Mohan Pammi, Ramasubbareddy Dhanireddy, Ashley Ross, Phillip Gordon, Antonio Arrieta, Kathleen A. Kennedy, Wiley A. Schell, P. Brian Smith
Objectives Extremely premature infants are at high risk of developing invasive candidiasis; fluconazole prophylaxis is safe and effective for reducing invasive candidiasis in this population but further study is needed. We sought to better understand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c6d76defadfd03a4ad7ea649cbea95
https://europepmc.org/articles/PMC6927883/
https://europepmc.org/articles/PMC6927883/
Autor:
Brenda B. Poindexter, Janice E. Sullivan, Jennifer Le, Adriana H. Tremoulet, Edmund V. Capparelli, Sandy Ian U. Chong, Matthew M. Laughon, Jamie Gao, Paula Delmore, Andrea Salgado, Daniel K. Benjamin, Michael Cohen-Wolkowiez, Chiara Melloni
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:3013-3020
Although ampicillin is the most commonly used drug in neonates, developmental pharmacokinetic (PK) data to guide dosing are lacking. Ampicillin is primarily renally eliminated, and developmental changes are expected to influence PK. We conducted an o
Autor:
Jonathan Nedrelow, Jeremiah D. Momper, P. Brian Smith, Daniel K. Benjamin, Jamie Gao, Kelly C. Wade, Girija Natarajan, Edmund V. Capparelli, Ramasubbareddy Dhanireddy, Mark L. Hudak, Anand Kantak, Matt Laughon, Gratias Mundakel, James J. Cummings
Publikováno v:
Antimicrobial agents and chemotherapy, vol 60, iss 9
Fluconazole is an effective agent for prophylaxis of invasive candidiasis in premature infants. The objective of this study was to characterize the population pharmacokinetics (PK) and dosing requirements of fluconazole in infants with birth weights
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199266a115c2a7162587a348d887c1ea
https://escholarship.org/uc/item/9qs0z7f4
https://escholarship.org/uc/item/9qs0z7f4
Autor:
Edmund V. Capparelli, Barry T. Bloom, Jamie Gao, Daniel K. Benjamin, Lisa Castro, P B Smith, C. Zhou, Kevin M. Watt, Michael Cohen-Wolkowiez, B. Poindexter
Publikováno v:
Antimicrobial agents and chemotherapy. 58(5)
Piperacillin-tazobactam is often given to infants with severe infection in spite of limited pharmacokinetics (PK) data. We evaluated piperacillin-tazobactam PK in premature and term infants of ages